Improved daytime spirometric efficacy of tiotropium compared with salmeterol in patients with COPD
Authors:
- D.D. BriggsDBD.D. Briggs
- H. CovelliHCH. Covelli
- R. LapidusRLR. Lapidus
- S. BhattycharyaSBS. Bhattycharya
- S. KestenSKS. Kesten
- C. CassinoCCC. Cassino
- 1 December 2005
- journal article
- research article
- Published by Elsevier in Pulmonary Pharmacology & Therapeutics
- Vol. 18 (6) , 397-404
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paperEuropean Respiratory Journal, 2004
- Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary diseaseThorax, 2003
- Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPDThorax, 2003
- A 6-Month, Placebo-Controlled Study Comparing Lung Function and Health Status Changes in COPD Patients Treated With Tiotropium or SalmeterolChest, 2002
- Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropiumEuropean Respiratory Journal, 2002
- A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary diseaseEuropean Respiratory Journal, 2002
- Effective Delivery of Particles with the HandiHaler® Dry Powder Inhalation System over a Range of Chronic Obstructive Pulmonary Disease SeverityJournal of Aerosol Medicine, 2001
- Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2000
- Tiotropium (SPIRIVA™): Mechanistical considerations and clinical profile in obstructive lung diseaseLife Sciences, 1999
- Standardization of Spirometry, 1994 Update. American Thoracic SocietyAmerican Journal of Respiratory and Critical Care Medicine, 1995